244 related articles for article (PubMed ID: 21835069)
1. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.
Lee SH; Yim JJ; Kim HJ; Shim TS; Seo HS; Cho YS; Lee HK; Lee YM; Lee EJ; Lew WJ
Epidemiol Infect; 2012 Jun; 140(6):1028-35. PubMed ID: 21835069
[TBL] [Abstract][Full Text] [Related]
2. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak.
Song Q; Guo H; Zhong H; Liu Z; Chen X; Wang C; Touzjian N; Lv Y; Lu X; Wang Q
Int J Infect Dis; 2012 Jul; 16(7):e522-6. PubMed ID: 22542006
[TBL] [Abstract][Full Text] [Related]
5. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
[TBL] [Abstract][Full Text] [Related]
6. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
[TBL] [Abstract][Full Text] [Related]
7. Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay.
Machado A; Emodi K; Takenami I; Finkmoore BC; Barbosa T; Carvalho J; Cavalcanti L; Santos G; Tavares M; Mota M; Barreto F; Reis MG; Arruda S; Riley LW
Int J Tuberc Lung Dis; 2009 Apr; 13(4):446-53. PubMed ID: 19335949
[TBL] [Abstract][Full Text] [Related]
8. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial.
Chan PC; Yang CH; Chang LY; Wang KF; Lu BY; Lu CY; Shao PL; Hsueh PR; Fang CT; Huang LM
Int J Tuberc Lung Dis; 2012 May; 16(5):633-8. PubMed ID: 22410137
[TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
11. Tuberculin skin test and interferon-γ release assay show better correlation after the tuberculin 'window period' in tuberculosis contacts.
Anibarro L; Trigo M; Villaverde C; Pena A; González-Fernández A
Scand J Infect Dis; 2011 Jul; 43(6-7):424-9. PubMed ID: 21332285
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
[TBL] [Abstract][Full Text] [Related]
13. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
[TBL] [Abstract][Full Text] [Related]
14. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
[TBL] [Abstract][Full Text] [Related]
15. Combined use of QuantiFERON-TB Gold assay and chest computed tomography in a tuberculosis outbreak.
Lew WJ; Jung YJ; Song JW; Jang YM; Kim HJ; Oh YM; Lee SD; Kim WS; Kim DS; Kim WD; Shim TS
Int J Tuberc Lung Dis; 2009 May; 13(5):633-9. PubMed ID: 19383198
[TBL] [Abstract][Full Text] [Related]
16. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities.
Grinsdale JA; Ho CS; Banouvong H; Kawamura LM
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1614-20. PubMed ID: 22118167
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
Singla N; Singla R; Jain G; Habib L; Behera D
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
[TBL] [Abstract][Full Text] [Related]
19. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
Noh CS; Kim HI; Choi H; Kim Y; Kim CH; Choi JH; Hyun IG; Baek MS
Respir Med; 2019 Oct; 157():52-58. PubMed ID: 31522030
[TBL] [Abstract][Full Text] [Related]
20. Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.
Bloss E; Kuksa L; Holtz TH; Riekstina V; Skripconoka V; Kammerer S; Leimane V
Int J Tuberc Lung Dis; 2010 Mar; 14(3):275-81. PubMed ID: 20132617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
